Liraglutide
A GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One of the first GLP-1 medications widely used for weight loss before semaglutide.
Details
- Category
- weight-loss
- Administration
- Subcutaneous injection (daily)
- Prescription Required
- Yes
- Also known as
- Saxenda, Victoza
Common Uses
- Weight loss
- Appetite suppression
- Blood sugar regulation
- Cardiovascular risk reduction